Hayden Michael R

SEC Form 4 insider
AbCellera Biologics Inc. ($ABCL)
1 thesis · first seen Aug 13, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d000———
3d1100%-1.6%-1.6%
1w1100%-0.5%-0.5%
1m000———
3m000———
6m000———
1y000———

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$ABCLSEC Form 4bullish
Hayden Michael R · AbCellera Biologics Inc. · 47d agono track record yet
Long 46,387 shares of ABCL
Bought 46,387 @ $10.37 avg · $481,033 · 2026-08-12

Form 4: Hayden Michael R bought ABCL

Hayden Michael R (Director at AbCellera Biologics Inc.) reported an open-market purchase of 46,387 shares of ABCL at an average $10.37, roughly $481,033, in a Form 4 filed 2026-08-14.

At post $11.38Now $12.63+11.0% since postedas of Sep 18, 4:30 PM ET
1d—
3d-1.6%
1w-0.5%
1m-4.3%
3m—
6m—
1y—
View filing on SEC.gov →

End of results.